5 employees
Empros Pharma develops pharmaceutical treatments against overweight and obesity.
2014
$4.3M
from 2 investors over 2 rounds
Empros Pharma raised $4.3M on July 1, 2019
Investors: Flerie Invest
Empros Pharma raised undisclosed on November 1, 2013